Despite being a small company, Fluicell has already positioned itself as a pioneer in the field of single-cell investigations by developing innovative technologies. To reach such heights, the company's products are based on advanced microfluidic technology, allowing for the precise control of fluids within a biomedical research setting. To learn more about this technology and how Fluicell has leveraged it in its product development, BioStock reached out to the company's co-founder and CTO Gavin Jeffries.

Read the full interview with Gavin Jeffries at biostock.se:

https://www.biostock.se/en/fluicell-harnessing-microfluidics-to-spearhead-the-biomedical-field/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

https://news.cision.com/fluicell/r/biostock--fluicell-harnessing-microfluidics-to-spearhead-the-biomedical-field,c3260193

(c) 2020 Cision. All rights reserved., source Press Releases - English